Financial Tearsheet

Company Overview

Tenax Therapeutics Inc (NASDAQ:TENX)

Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. 

Stock Performance

Today's Open 0.7550
Volume 424,983
Day Range 0.7000 - 0.7550
52 Week Range 0.4150 - 2.9400
Bid/Ask 0.7360 / 0.7390
Bid/Ask Size 3,400 X 400
Previous Close 0.7385
Market Cap 20.7 million
Shares Outstanding 28.12 million
Dividend/Yield 0.0000 / 0.0000%
EPS (TTM) 0.530103
P/E Ratio (TTM) 1.3884

Recent XBRL Filings

Filing Date Form Type Description View
Nov 09, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Aug 09, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
May 10, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Dec 10, 2015 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 09, 2015 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

John Kelley, Chief Executive Officer

Michael B. Jebsen, Chief Financial Officer

Paula Bokesch, M.D., Chief Medical Officer

Douglas Hay, PhD, EVP of Regulatory Affairs

Nancy Hecox, EVP, Legal Affairs, General Counsel, and Corporate Secretary

Doug Randall, EVP of Commercial and Business Operations

Board of Directors

Dr. Ronald Blanck, Chairman

John Kelley, Chief Executive Officer

Anthony DiTonno, Director

James Mitchum, Director

Gregory Pepin, Director

Gerald Proehl, Director

Chris A. Rallis, Director